Health
Drugmaker Sues Competitor Over Ad Campaign
Novo Nordisk filed a lawsuit against Eli Lilly, alleging deceptive advertising that uses outdated clinical trials to promote its GLP-1 drugs. The case highlights ongoing tensions in the pharmaceutical industry.
Coverage timeline — 1 article
STAT News
Novo Nordisk sued Eli Lilly for allegedly running a “deceptive” ad campaign that uses “outdated clinical trials” to make its obesity and diabetes drugs appear more effective.
2026-07-21 11:35 UTC